person · Reporting owner
Harrison Kenneth Ph.D.
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Edgewise Therapeutics, Inc.EWTX · Entity 3965 | Director | March 25, 2021 | March 25, 2021 |
| OnKure Therapeutics, Inc.RPHM · Entity 6550 | Director | April 08, 2021 | May 26, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Edgewise Therapeutics, Inc.
Report date March 25, 2021 · Filed March 25, 2021
This filing explicitly reported no securities owned.
OnKure Therapeutics, Inc.
Report date April 08, 2021 · Filed May 26, 2021 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
Holding disclosure · report date 2021-04-08 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance 0 F1: On April 12, 2021, the reporting person mistakenly filed a Form 4 reporting a grant of a stock option (right to buy) of 14,000 shares that did not in fact occur. |
Filing footnotes · ownership attribution and instrument terms
F1: On April 12, 2021, the reporting person mistakenly filed a Form 4 reporting a grant of a stock option (right to buy) of 14,000 shares that did not in fact occur.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 08, 2021 Filed Apr 12, 2021 15:16 UTC | OnKure Therapeutics, Inc. RPHM · Entity 6550 | GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026339 · doc4.xml · derivative · entry 1 Harrison Kenneth Ph.D. · CIK 0001852977 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-04-07 F1 · derivative.exercise_date: The shares subject to the option vest on April 8, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.